{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:31:59Z","timestamp":1790893919368,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11427-024-2849-2","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T22:36:09Z","timestamp":1747348569000},"page":"2316-2331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Single-cell sequencing and spatial transcriptomics reveal FAS+ T cell and autophagy-related signatures predicting chemoimmunotherapy response in diffuse large B-cell lymphoma patients"],"prefix":"10.1007","volume":"68","author":[{"given":"Ning","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"2849_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ijc.23881","volume":"124","author":"WZ Ai","year":"2009","unstructured":"Ai, W.Z., Hou, J., Zeiser, R., Czerwinski, D., Negrin, R.S., and Levy, R. (2009). Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. Intl J Cancer 124, 239\u2013244.","journal-title":"Intl J Cancer"},{"key":"2849_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K., Chen, C., Wang, D.D., Xu, X., Qu, C., Yamaza, T., Cai, T., Chen, W.J., Sun, L., and Shi, S. (2012). Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell 10, 544\u2013555.","journal-title":"Cell Stem Cell"},{"key":"2849_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511.","journal-title":"Nature"},{"key":"2849_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage, J.O., Gascoyne, R.D., Lunning, M.A., and Cavalli, F. (2017). Non-Hodgkin lymphoma. Lancet 390, 298\u2013310.","journal-title":"Lancet"},{"key":"2849_CR5","first-page":"124","volume":"5","author":"M Ataollahi","year":"2008","unstructured":"Ataollahi, M., Salehi, M., Doostan, I., Kabiri, Z., Mohajeri, M., Mahmoodi, F., Shokouhi, R., Javan, S., Meshkibaf, M.H., and Miladpoor, B. (2008). Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma. Iran J Immunol 5, 124\u2013130.","journal-title":"Iran J Immunol"},{"key":"2849_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3324\/haematol.2019.243626","volume":"106","author":"M Autio","year":"2021","unstructured":"Autio, M., Leivonen, S.K., Br\u00fcck, O., Mustjoki, S., M\u00e9sz\u00e1ros J\u00f8rgensen, J., Karjalainen-Lindsberg, M.L., Beiske, K., Holte, H., Pellinen, T., and Lepp\u00e4, S. (2021). Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma. Haematologica 106, 718\u2013729.","journal-title":"Haematologica"},{"key":"2849_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/hep.22638","volume":"49","author":"DS Bai","year":"2009","unstructured":"Bai, D.S., Dai, Z., Zhou, J., Liu, Y.K., Qiu, S.J., Tan, C.J., Shi, Y.H., Huang, C., Wang, Z., He, Y.F., et al. (2009). Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology 49, 460\u2013470.","journal-title":"Hepatology"},{"key":"2849_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bjh.12440","volume":"162","author":"C Bertolo","year":"2013","unstructured":"Bertolo, C., Roa, S., Sagardoy, A., Mena-Varas, M., Robles, E.F., Martinez-Ferrandis, J. I., Sagaert, X., Tousseyn, T., Orta, A., Lossos, I.S., et al. (2013). LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. Br J Haematol 162, 621\u2013630.","journal-title":"Br J Haematol"},{"key":"2849_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","volume":"18","author":"EC Borden","year":"2019","unstructured":"Borden, E.C. (2019). Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov 18, 219\u2013234.","journal-title":"Nat Rev Drug Discov"},{"key":"2849_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/labmed\/lmaa027","volume":"52","author":"H Boustani","year":"2021","unstructured":"Boustani, H., Khodadi, E., and Shahidi, M. (2021). Autophagy in hematological malignancies: molecular aspects in leukemia and lymphoma. Lab Med 52, 16\u201323.","journal-title":"Lab Med"},{"key":"2849_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B., Stewart, C., Dunford, A.J., Kim, J., Kamburov, A., Redd, R.A., Lawrence, M.S., Roemer, M.G.M., Li, A.J., Ziepert, M., et al. (2018). Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24, 679\u2013690.","journal-title":"Nat Med"},{"key":"2849_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1205406","volume":"368","author":"AMK Choi","year":"2013","unstructured":"Choi, A.M.K., Ryter, S.W., and Levine, B. (2013). Autophagy in human health and disease. N Engl J Med 368, 651\u2013662.","journal-title":"N Engl J Med"},{"key":"2849_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8586354","volume":"2019","author":"AI Cioroianu","year":"2019","unstructured":"Cioroianu, A.I., Stinga, P.I., Sticlaru, L., Cioplea, M.D., Nichita, L., Popp, C., and Staniceanu, F. (2019). Tumor microenvironment in diffuse large B-cell lymphoma: role and prognosis. Anal Cell Pathol 2019, 1\u20139.","journal-title":"Anal Cell Pathol"},{"key":"2849_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier, B., Thieblemont, C., Van Den Neste, E., Lepeu, G., Plantier, I., Castaigne, S., Lefort, S., Marit, G., Macro, M., Sebban, C., et al. (2010). Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood 116, 2040\u20132045.","journal-title":"Blood"},{"key":"2849_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","volume":"125","author":"C Correia","year":"2015","unstructured":"Correia, C., Schneider, P.A., Dai, H., Dogan, A., Maurer, M.J., Church, A.K., Novak, A. J., Feldman, A.L., Wu, X., Ding, H., et al. (2015). BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125, 658\u2013667.","journal-title":"Blood"},{"key":"2849_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-024-00605-w","volume":"12","author":"L Dai","year":"2024","unstructured":"Dai, L., Fan, G., Xie, T., Li, L., Tang, L., Chen, H., Shi, Y., and Han, X. (2024). Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma. Biomark Res 12, 58.","journal-title":"Biomark Res"},{"key":"2849_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","volume":"2011","author":"JW Friedberg","year":"2011","unstructured":"Friedberg, J.W. (2011). Relapsed\/refractory diffuse large B-cell lymphoma. Hematology 2011, 498\u2013505.","journal-title":"Hematology"},{"key":"2849_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2017-04-737320","volume":"130","author":"JW Friedberg","year":"2017","unstructured":"Friedberg, J.W. (2017). How I treat double-hit lymphoma. Blood 130, 590\u2013596.","journal-title":"Blood"},{"key":"2849_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R., and Seoighe, C. (2010). A flexible R package for nonnegative matrix factorization. BMC Bioinf 11, 367.","journal-title":"BMC Bioinf"},{"key":"2849_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","volume":"129","author":"S Gayle","year":"2017","unstructured":"Gayle, S., Landrette, S., Beeharry, N., Conrad, C., Hernandez, M., Beckett, P., Ferguson, S.M., Mandelkern, T., Zheng, M., Xu, T., et al. (2017). Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood 129, 1768\u20131778.","journal-title":"Blood"},{"key":"2849_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","volume":"36","author":"RIK Geltink","year":"2018","unstructured":"Geltink, R.I.K., Kyle, R.L., and Pearce, E.L. (2018). Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol 36, 461\u2013488.","journal-title":"Annu Rev Immunol"},{"key":"2849_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature13300","volume":"509","author":"AD Gitlin","year":"2014","unstructured":"Gitlin, A.D., Shulman, Z., and Nussenzweig, M.C. (2014). Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509, 637\u2013640.","journal-title":"Nature"},{"key":"2849_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/S0140-6736(18)33005-8","volume":"393","author":"LL Hammitt","year":"2019","unstructured":"Hammitt, L.L., Etyang, A.O., Morpeth, S.C., Ojal, J., Mutuku, A., Mturi, N., Moisi, J.C., Adetifa, I.M., Karani, A., Akech, D.O., et al. (2019). Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet 393, 2146\u20132154.","journal-title":"Lancet"},{"key":"2849_CR24","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","volume":"121","author":"S Hu","year":"2013","unstructured":"Hu, S., Xu-Monette, Z.Y., Tzankov, A., Green, T., Wu, L., Balasubramanyam, A., Liu, W., Visco, C., Li, Y., Miranda, R.N., et al. (2013). MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood 121, 4021\u20134031.","journal-title":"Blood"},{"key":"2849_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.humpath.2010.12.014","volume":"42","author":"JJ Huang","year":"2011","unstructured":"Huang, J.J., Zhu, Y.J., Lin, T.Y., Jiang, W.Q., Huang, H.Q., and Li, Z.M. (2011). Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. Hum Pathol 42, 1459\u20131466.","journal-title":"Hum Pathol"},{"key":"2849_CR26","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-11-0267","volume":"17","author":"J Iqbal","year":"2011","unstructured":"Iqbal, J., Meyer, P.N., Smith, L.M., Johnson, N.A., Vose, J.M., Greiner, T.C., Connors, J. M., Staudt, L.M., Rimsza, L., Jaffe, E., et al. (2011). BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clin Cancer Res 17, 7785\u20137795.","journal-title":"Clin Cancer Res"},{"key":"2849_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2005.03.4264","volume":"24","author":"J Iqbal","year":"2006","unstructured":"Iqbal, J., Neppalli, V.T., Wright, G., Dave, B.J., Horsman, D.E., Rosenwald, A., Lynch, J., Hans, C.P., Weisenburger, D.D., Greiner, T.C., et al. (2006). BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol 24, 961\u2013968.","journal-title":"J Clin Oncol"},{"key":"2849_CR28","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1080\/15548627.2020.1815439","volume":"16","author":"B Janji","year":"2020","unstructured":"Janji, B., Hasmim, M., Parpal, S., De Milito, A., Berchem, G., and Noman, M.Z. (2020). Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3\/VPS34. Autophagy 16, 2110\u20132111.","journal-title":"Autophagy"},{"key":"2849_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000351979","volume":"5","author":"DJ Klionsky","year":"2013","unstructured":"Klionsky, D.J., and Codogno, P. (2013). The mechanism and physiological function of macroautophagy. J Innate Immun 5, 427\u2013433.","journal-title":"J Innate Immun"},{"key":"2849_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1600-0609.2006.00631.x","volume":"76","author":"Y Kojima","year":"2006","unstructured":"Kojima, Y., Tsurumi, H., Goto, N., Shimizu, M., Kasahara, S., Yamada, T., Kanemura, N., Hara, T., Sawada, M., Saio, M., et al. (2006). Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome. Eur J Haematol 76, 465\u2013472.","journal-title":"Eur J Haematol"},{"key":"2849_CR31","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy, S.E., Barrans, S.L., Beer, P.A., Painter, D., Smith, A.G., Roman, E., Cooke, S.L., Ruiz, C., Glover, P., Van Hoppe, S.J.L., et al. (2020). Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood 135, 1759\u20131771.","journal-title":"Blood"},{"key":"2849_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4062\/biomolther.2012.20.3.280","volume":"20","author":"HJ Lee","year":"2012","unstructured":"Lee, H.J., and Kim, K.W. (2012). Suppression of HIF-1\u03b1 by valproic acid sustains self-renewal of mouse embryonic stem cells under hypoxia in vitro. Biomol Ther 20, 280\u2013285.","journal-title":"Biomol Ther"},{"key":"2849_CR33","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008). Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359, 2313\u20132323.","journal-title":"N Engl J Med"},{"key":"2849_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","volume":"33","author":"CW Li","year":"2018","unstructured":"Li, C.W., Lim, S.O., Chung, E.M., Kim, Y.S., Park, A.H., Yao, J., Cha, J.H., Xia, W., Chan, L.C., Kim, T., et al. (2018a). Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1. Cancer Cell 33, 187\u2013201.e10.","journal-title":"Cancer Cell"},{"key":"2849_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li, S., Young, K.H., and Medeiros, L.J. (2018b). Diffuse large B-cell lymphoma. Pathology 50, 74\u201387.","journal-title":"Pathology"},{"key":"2849_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15384101.2018.1560718","volume":"18","author":"Y Li","year":"2019","unstructured":"Li, Y., Zhou, X., Zhang, Y., Yang, J., Xu, Y., Zhao, Y., and Wang, X. (2019). CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma. Cell Cycle 18, 379\u2013394.","journal-title":"Cell Cycle"},{"key":"2849_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41467-020-20448-x","volume":"12","author":"D Liang","year":"2021","unstructured":"Liang, D., Xue, J., Geng, L., Zhou, L., Lv, B., Zeng, Q., Xiong, K., Zhou, H., Xie, D., Zhang, F., et al. (2021). Cellular and molecular landscape of mammalian sinoatrial node revealed by single-cell RNA sequencing. Nat Commun 12, 287.","journal-title":"Nat Commun"},{"key":"2849_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2019.03.017","volume":"114","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Zhang, H., Wang, Z.Y., Wu, P., and Gong, W. (2019). 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy\/pSTAT3. Eur J Cancer 114, 8\u201324.","journal-title":"Eur J Cancer"},{"key":"2849_CR39","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.mcpro.2023.100625","volume":"22","author":"N Lou","year":"2023","unstructured":"Lou, N., Wang, G., Wang, Y., Xu, M., Zhou, Y., Tan, Q., Zhong, Q., Zhang, L., Zhang, X., Liu, S., et al. (2023). Proteomics identifies circulating TIMP-1 as a prognostic biomarker for diffuse large B-cell lymphoma. Mol Cell Proteomics 22, 100625.","journal-title":"Mol Cell Proteomics"},{"key":"2849_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P.R., Harrington, L.E., O\u2019Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., Hatton, R.D., Wahl, S.M., Schoeb, T.R., and Weaver, C.T. (2006). Transforming growth factor-\u03b2 induces development of the TH17 lineage. Nature 441, 231\u2013234.","journal-title":"Nature"},{"key":"2849_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","volume":"36","author":"S Nagata","year":"2018","unstructured":"Nagata, S. (2018). Apoptosis and clearance of apoptotic cells. Annu Rev Immunol 36, 489\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"2849_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/modpathol.2010.80","volume":"23","author":"G Nicotra","year":"2010","unstructured":"Nicotra, G., Mercalli, F., Peracchio, C., Castino, R., Follo, C., Valente, G., and Isidoro, C. (2010). Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 23, 937\u2013950.","journal-title":"Mod Pathol"},{"key":"2849_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fonc.2020.00351","volume":"10","author":"G Opinto","year":"2020","unstructured":"Opinto, G., Vegliante, M.C., Negri, A., Skrypets, T., Loseto, G., Pileri, S.A., Guarini, A., and Ciavarella, S. (2020). The tumor microenvironment of DLBCL in the computational era. Front Oncol 10, 351.","journal-title":"Front Oncol"},{"key":"2849_CR44","doi-asserted-by":"publisher","first-page":"e20201173","DOI":"10.1084\/jem.20201173","volume":"218","author":"R Razzaghi","year":"2021","unstructured":"Razzaghi, R., Agarwal, S., Kotlov, N., Plotnikova, O., Nomie, K., Huang, D.W., Wright, G.W., Smith, G.A., Li, M., Takata, K., et al. (2021). Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma. J Exp Med 218, e20201173.","journal-title":"J Exp Med"},{"key":"2849_CR45","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., et al. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346, 1937\u20131947.","journal-title":"N Engl J Med"},{"key":"2849_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","volume":"101","author":"S Sakaguchi","year":"2000","unstructured":"Sakaguchi, S. (2000). Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455\u2013458.","journal-title":"Cell"},{"key":"2849_CR47","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R., Wright, G.W., Huang, D.W., Johnson, C.A., Phelan, J.D., Wang, J.Q., Roulland, S., Kasbekar, M., Young, R.M., Shaffer, A.L., et al. (2018). Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378, 1396\u20131407.","journal-title":"N Engl J Med"},{"key":"2849_CR48","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/leu.2011.378","volume":"26","author":"JM Schuetz","year":"2012","unstructured":"Schuetz, J.M., Johnson, N.A., Morin, R.D., Scott, D.W., Tan, K., Ben-Nierah, S., Boyle, M., Slack, G.W., Marra, M.A., Connors, J.M., et al. (2012). BCL2 mutations in diffuse large B-cell lymphoma. Leukemia 26, 1383\u20131390.","journal-title":"Leukemia"},{"key":"2849_CR49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott, D.W., and Gascoyne, R.D. (2014). The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 14, 517\u2013534.","journal-title":"Nat Rev Cancer"},{"key":"2849_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon, N., Friedman, J., Hastie, T., and Tibshirani, R. (2011). Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Soft 39, 1\u201313.","journal-title":"J Stat Soft"},{"key":"2849_CR51","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen, C.B., Luca, B.A., Esfahani, M.S., Azizi, A., Sworder, B.J., Nabet, B.Y., Kurtz, D. M., Liu, C.L., Khameneh, F., Advani, R.H., et al. (2021). The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell 39, 1422\u20131437.e10.","journal-title":"Cancer Cell"},{"key":"2849_CR52","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209\u2013249.","journal-title":"CA Cancer J Clin"},{"key":"2849_CR53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., and Stockinger, B. (2006). TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179\u2013189.","journal-title":"Immunity"},{"key":"2849_CR54","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1007\/s00262-023-03428-0","volume":"72","author":"S Wang","year":"2023","unstructured":"Wang, S., Fan, G., Li, L., He, Y., Lou, N., Xie, T., Dai, L., Gao, R., Yang, M., Shi, Y., et al. (2023). Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC. Cancer Immunol Immunother 72, 2423\u20132442.","journal-title":"Cancer Immunol Immunother"},{"key":"2849_CR55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","volume":"21","author":"WH Wilson","year":"2015","unstructured":"Wilson, W.H., Young, R.M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.J., Williams, P.M., Shaffer, A.L., Gerecitano, J., et al. (2015). Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med 21, 922\u2013926.","journal-title":"Nat Med"},{"key":"2849_CR56","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1080\/15548627.2020.1769973","volume":"16","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto, K., Venida, A., Perera, R.M., and Kimmelman, A.C. (2020a). Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. Autophagy 16, 1524\u20131525.","journal-title":"Autophagy"},{"key":"2849_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto, K., Venida, A., Yano, J., Biancur, D.E., Kakiuchi, M., Gupta, S., Sohn, A.S. W., Mukhopadhyay, S., Lin, E.Y., Parker, S.J., et al. (2020b). Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581, 100\u2013105.","journal-title":"Nature"},{"key":"2849_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","volume":"3","author":"H Yao","year":"2019","unstructured":"Yao, H., Lan, J., Li, C., Shi, H., Brosseau, J.P., Wang, H., Lu, H., Fang, C., Zhang, Y., Liang, L., et al. (2019). Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng 3, 306\u2013317.","journal-title":"Nat Biomed Eng"},{"key":"2849_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ebiom.2019.01.054","volume":"40","author":"N Zhang","year":"2019","unstructured":"Zhang, N., Dou, Y., Liu, L., Zhang, X., Liu, X., Zeng, Q., Liu, Y., Yin, M., Liu, X., Deng, H., et al. (2019). SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1. EBioMedicine 40, 151\u2013162.","journal-title":"EBioMedicine"},{"key":"2849_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1159\/000511638","volume":"105","author":"Q Zhuang","year":"2021","unstructured":"Zhuang, Q., Fan, M., Shen, J., Chen, Z., Xue, D., Lu, H., Xu, R., He, X., and Hou, J. (2021). Overexpression of Capns1 predicts poor prognosis and correlates with tumor progression in renal cell carcinoma. Urol Int 105, 697\u2013704.","journal-title":"Urol Int"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2849-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2849-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2849-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:37:21Z","timestamp":1757173041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2849-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2849-2","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. This study was approved by the Ethics Committee of the Cancer Hospital of the Chinese Academy of Medical Sciences (19-019\/1804). The study was executed according to the principles of the Declaration of Helsinki, and since the plasma samples used in this study were leftovers of routine clinical tests waivers of informed consent were requested.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}